Solazyme Inc. (NASDAQ:TVIA)’s share price traded down 3.3% on Monday . The company traded as low as $2.61 and last traded at $2.62, with a volume of 165,022 shares traded. The stock had previously closed at $2.71.

The firm has a 50-day moving average price of $2.49 and a 200-day moving average price of $2.16. The firm’s market capitalization is $223.27 million.

Solazyme (NASDAQ:TVIA) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.26) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.29) by $0.03. The company had revenue of $9.90 million for the quarter, compared to analysts’ expectations of $10.85 million. The business’s quarterly revenue was down 15.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.40 EPS. On average, equities research analysts forecast that Solazyme Inc. will post ($1.15) EPS for the current year.

In related news, CFO Tyler Painter sold 12,500 shares of Solazyme stock in a transaction dated Tuesday, June 7th. The stock was sold at an average price of $2.67, for a total value of $33,375.00. Following the completion of the transaction, the chief financial officer now owns 400,337 shares in the company, valued at approximately $1,068,899.79. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.